Bridgewater Associates’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-107,217
| Closed | -$1.34M | – | 770 |
|
|
2023
Q2 | $1.34M | Sell |
107,217
-4,217
| -4% | -$52.7K | 0.01% | 534 |
|
|
2023
Q1 | $1.3M | Sell |
111,434
-932
| -0.8% | -$10.9K | 0.01% | 524 |
|
|
2022
Q4 | $1.19M | Sell |
112,366
-36,265
| -24% | -$385K | 0.01% | 623 |
|
|
2022
Q3 | $1.44M | Sell |
148,631
-2,477
| -2% | -$24K | 0.01% | 625 |
|
|
2022
Q2 | $2.19M | Buy |
151,108
+25,351
| +20% | +$367K | 0.01% | 667 |
|
|
2022
Q1 | $3.29M | Buy |
125,757
+31,662
| +34% | +$827K | 0.01% | 564 |
|
|
2021
Q4 | $3.73M | Buy |
94,095
+7,695
| +9% | +$305K | 0.02% | 357 |
|
|
2021
Q3 | $4.32M | Buy |
86,400
+6,181
| +8% | +$309K | 0.02% | 309 |
|
|
2021
Q2 | $4.45M | Buy |
+80,219
| New | +$4.45M | 0.03% | 352 |
|